Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China 2021-02-04 21:00
Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries 2021-02-04 18:41
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab 2021-02-03 23:45
More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept 2021-02-03 22:00
Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program 2021-02-03 22:00
Nippon Express (Thailand) Obtains GDP Certification for Domestic Transport Services 2021-02-02 14:00
Kintor's GT20029 IND for PROTAC AR Degrader Was Accepted by NMPA 2021-02-02 12:11
DW Healthcare Partners Invests in Parnell 2021-02-02 08:23
Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet 2021-02-01 14:00
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd. 2021-01-30 07:38
Nippon Express Bangladesh Obtains GDP Certification for Air Cargo Import/Export Services 2021-01-29 15:00
Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA 2021-01-28 22:00
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA 2021-01-27 08:26
I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer 2021-01-26 05:05
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine 2021-01-26 01:18
China Biologic Announces Extraordinary General Meeting of Shareholders 2021-01-25 21:44
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19 2021-01-22 12:00
China Jo-Jo Drugstores Hosts the First Suppliers Conference in China 2021-01-21 21:30
Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody JMB2002 2021-01-20 13:53
Gracell Biotechnologies Receives IND Approval from China NMPA for GC019F, a FasTCAR-Enabled CAR-T Therapy for the Treatment of Relapsed or Refractory Adult B-ALL 2021-01-19 19:30
1 110 111 112 113 114 165